biogenesis records

MLB’s civil case against Biogenesis and others is still proceeding. One of the others is interesting.

38 Comments

Part of MLB’s deal with Anthony Bosch is that the league will dismiss the lawsuit it filed against him. It hasn’t done that yet. Which isn’t terribly surprising as MLB is still probably wanting to ensure continued cooperation from him and to ensure that they get something of value from him. The court likely won’t make the league do anything until various deadlines approach that require its attention.

But there are other defendants besides Bosch. One of them is his former colleague who is alleged by MLB to have also given players PEDs. His name is Carlos Acevedo and just this afternoon his latest request to have the lawsuit against him dismissed was denied, so he’s still in MLB’s crosshairs.

Acevedo is an interesting character here. I presume his defense — in addition to some statute of limitations grounds mentioned in the linked article — will be that he had nothing to do with Biogenesis. Which may be technically true. However, Acevedo and Bosch were partners in a predecessor anti-aging clinic before they had a falling out and went their separate ways. And it wasn’t too terribly long ago that this happened. The third partner in that clinic, a guy named Xavier Romero, left with Acevedo. He told the New York Times a couple of months ago that (a) he didn’t do anything with athletes; and (b) Bosch was a wreck and that he was surprised that he’d be able to lure baseball players as clients. The article also noted that Acevedo had a good reputation in the anti-aging community and worked with solid medical companies in the past.

Which makes me wonder about Major League Baseball’s interest in Acevedo. Do they think that he was a source of PEDs to players? If so, you’d think he’d be a better target for cooperation than Bosch, given his apparently more august standing in the world, his greater ability (in Romano’s view, one presumes) to lure high profile clients; and, by extension, his fewer credibility problems. On the other hand, if they don’t think he was involved, this lawsuit, with respect to Acevedo anyway, stinks to high heavens.

While I disagreed with Major League Baseball’s lawsuit when it was filed and still believe it’s the weakest legal sauce imaginable, I don’t think MLB is in the business of harassing truly innocent parties, which is what they’d be doing here if Acevedo didn’t have some sort of involvement in providing drugs to players. Which makes me think that maybe they’re trying to do with Acevedo what they did with Bosch: flip him and get him to talk about players’ drug use. Which suggests that either MLB doesn’t think that it yet has the goods or that it’s being extremely deliberate as it builds its case.

If they do have the goods on the players, though, you’d think they’d quit pursuing Acevedo, right?

Report: Rangers interested in Royals’ Edinson Volquez

ST. LOUIS, MO - JUNE 29: Starter Edinson Volquez #36 of the Kansas City Royals pitches against the St. Louis Cardinals in the first inning at Busch Stadium on June 29, 2016 in St. Louis, Missouri.  (Photo by Dilip Vishwanat/Getty Images)
Dilip Vishwanat/Getty Images
2 Comments

Evan Grant of the Dallas Morning News reports that the entire Rangers “inner circle of front office personnel” was on hand to watch Edinson Volquez start for the Royals against the Rangers on Sunday. Volquez went six innings, giving up a lone run on seven hits and three walks with three strikeouts.

Volquez, 33, is earning $9.5 million this season and can become a free agent after the season if his team chooses to buy him out for $3 million instead of picking up their end of his $10 million mutual option for 2017. GM Jon Daniels said he was hoping the club would be able to avoid considering rentals, but as the club has dealt with injuries, the strength of the starting rotation has become a concern. Colby Lewis and Derek Holland are both on the disabled list. Yu Darvish has made only five starts since making his season debut in late May. Meanwhile, Kyle Lohse — who has given up 13 runs in two starts — has occupied the back of the rotation. A reliable starter would go along way towards helping the 57-42 Rangers fight to keep first place in the AL West.

Jon Morosi of FOX Sports also reports that the Rangers have shown interest in young Phillies right-hander Vince Velasquez, but they would pay a much higher price for him than for Volquez. Velasquez has a 3.34 ERA with a 103/34 K/BB ratio in 91 2/3 innings for the Phillies this season.

Report: Cubs, Yankees agree on Aroldis Chapman trade

NEW YORK, NY - JULY 17:  Aroldis Chapman #54 of the New York Yankees delivers a pitch in the ninth inning against the Boston Red Sox at Yankee Stadium on July 17, 2016 in the Bronx borough of New York City.  (Photo by Elsa/Getty Images)
Elsa/Getty Images
35 Comments

Update (12:28 PM EDT): CSN Chicago’s Patrick Mooney reports that 22-year-old outfielder Rashad Crawford is also headed to the Yankees. Crawford is not ranked among the Cubs’ best prospects. This season, at Single-A Myrtle Beach, he has hit .255/.327/.386 with 29 extra-base hits, 30 RBI, and 59 runs scored in 370 plate appearances.

*

The deal between the Cubs and Yankees involving closer Aroldis Chapman, first reported on Sunday, is complete according to Jon Heyman of Today’s Knuckleball. The Cubs will get Chapman while the Yankees will receive infield prospect Gleyber Torres, outfield prospect Billy McKinney, pitcher Adam Warren, and one more as yet unnamed player. Despite what yesterday’s report indicated, there is no contract extension for Chapman, so he can become a free agent after the season.

Torres, 19, is rated the Cubs’ #1 prospect and #24 overall in baseball by MLB Pipeline. The shortstop has spent the season with Single-A Myrtle Beach, batting .275/.359/.433 with nine home runs, 47 RBI, 62 runs scored, and 19 stolen bases in 409 plate appearances. The Cubs, however, already have Addison Russell at shortstop and have middle infield prospect Ian Happ.

McKinney, 21, is the Cubs’ #5 prospect and #75 overall in baseball. This season, with Double-A Tennessee, he has put up a .252/.355/.322 triple-slash line with 16 extra-base hits, 31 RBI and 37 runs scored in 349 PA. He suffered a hairline fracture in his right knee last year, which might explain why he’s been a bit lackluster with the bat this season.

Warren, 28, is a former Yankee as the club sent him to the Cubs in the Starlin Castro trade over the winter. He’s been unremarkable in one start and 28 relief appearances for the Cubs, posting a 5.91 ERA with a 27/19 K/BB ratio in 35 innings. Warren, earning $1.7 million this season, has two more years of arbitration eligibility remaining.

Since returning to the Yankees, Chapman has recorded 20 saves in 21 chances with a 2.01 ERA and a 44/8 K/BB ratio in 31 1/3 innings. Andrew Miller will likely move into the closer’s role with Dellin Betances setting up the eighth inning for the Yankees.

[Content note: The following will contain descriptions of an incident during which Chapman allegedly assaulted his girlfriend.]

Chapman, 28, served a 30-game suspension beginning at the start of the regular season due to an offseason incident during which he allegedly choked his girlfriend and fired off eight gunshots in his garage. The police didn’t file official charges.